Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:December 21, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:December 21, 2023Recruiting
Condition(s):Acute Myeloid Leukemia (AML)Last Updated:October 25, 2023Active, not recruiting
Condition(s):Refractory Follicular Lymphoma; Relapsed Follicular LymphomaLast Updated:January 19, 2023Active, not recruiting
Condition(s):Acute Myeloid Leukemia; Myelodysplastic Syndrome; Blastic Plasmacytoid Dendritic Cell NeoplasmLast Updated:June 22, 2023Recruiting
Condition(s):Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)Last Updated:January 9, 2024Recruiting
Condition(s):AML, AdultLast Updated:March 15, 2023Recruiting
Condition(s):Mantle Cell Lymphoma RefractoryLast Updated:September 28, 2023Recruiting
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromesLast Updated:July 24, 2023Recruiting
Condition(s):Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell LymphomaLast Updated:March 10, 2022Withdrawn
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:July 14, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.